SCHEMBL9868517

SCHEMBL9868517

N=C(NCCCc1c[nH]cn1)NCCSCc1ccc(Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.42
ALDH1A1 P00352 3/20 0.42
HPGD P15428 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
LMNA P02545 5/20 0.41
MEN1 O00255 2/20 0.41
HTT P42858 2/20 0.41
ALOX12 P18054 2/20 0.41
MAPT P10636 1/20 0.41
USP2 O75604 1/20 0.38
POLB P06746 3/20 0.38
ALPG P10696 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
GAA P10253 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9866034 0.89 ALDH1A1 (0.45) KMT2AALDH1A1HPGDLMNAMEN1
SCHEMBL9865647 0.89 GAA (0.45) KMT2AALDH1A1HPGDCYP1A2CYP2D6
SCHEMBL9876539 0.88 CYP1A2 (0.38) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL9865256 0.86 ALDH1A1 (0.45) KMT2AALDH1A1LMNAMEN1HTT
SCHEMBL9866021 0.85 TEAD1 (0.43) KMT2AALDH1A1LMNAMEN1HTT
SCHEMBL9866356 0.85 SMN1; SMN2 (0.35) KMT2AALDH1A1HPGDCYP1A2CYP3A4
SCHEMBL9867267 0.84 LMNA (0.35) KMT2AALDH1A1HPGDCYP1A2CYP3A4
SCHEMBL9866274 0.83 TEAD1 (0.38) KMT2AALDH1A1LMNAMEN1HTT
SCHEMBL9867335 0.83 EPHX2 (0.35) ALDH1A1HPGDLMNASMN1; SMN2
SCHEMBL9865393 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 US disclosed
EP-0199845-B1 IMIDAZOLYLALKYLGUANIDIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HEUMANN PHARMA GMBH & CO (DE) 1990-08-01 EP disclosed
EP-0199845-A1 Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them HEUMANN PHARMA GMBH & CO (DE) 1986-11-05 EP disclosed